SPORTS MEDICINE
Hyaluronic acid versus placebo injection on POD1 following ACL reconstruction
Am J Sports Med. 2016 Oct;44(10):2572-257860 patients scheduled for arthroscopic ACL reconstruction were randomized to receive an injection of either hyaluronic acid or placebo on the first day following the procedure. The purpose of this study was to compare measures of pain, function, and health-related quality of life between groups over a 12-month follow-up to determine if the use of hyaluronic acid can provide benefits in this patient population. The results demonstrated no significant differences between groups in clinical or functional scores. When comparing the active range of motion and leg girth between the operative limb and the contralateral limb, significantly smaller differences were observed in the HA group compared to the placebo at 1 and 2 months, respectively.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
